Published in J Clin Invest on June 02, 2005
Functional inhibition of osteoblastic cells in an in vivo mouse model of myeloid leukemia. Blood (2011) 2.27
Negative feedback in noncanonical NF-kappaB signaling modulates NIK stability through IKKalpha-mediated phosphorylation. Sci Signal (2010) 2.05
RelB is the NF-kappaB subunit downstream of NIK responsible for osteoclast differentiation. Proc Natl Acad Sci U S A (2008) 1.68
The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis. Arthritis Res Ther (2008) 1.68
RelA/p65 promotes osteoclast differentiation by blocking a RANKL-induced apoptotic JNK pathway in mice. J Clin Invest (2008) 1.52
Role of NF-κB in the skeleton. Cell Res (2010) 1.45
Regulation of Th17 cell differentiation and EAE induction by MAP3K NIK. Blood (2009) 1.29
NF-κB inducing kinase: a key regulator in the immune system and in cancer. Cytokine Growth Factor Rev (2010) 1.28
FHL2 inhibits the activated osteoclast in a TRAF6-dependent manner. J Clin Invest (2005) 1.25
Functions of nuclear factor kappaB in bone. Ann N Y Acad Sci (2010) 1.21
Antagonism of inhibitor of apoptosis proteins increases bone metastasis via unexpected osteoclast activation. Cancer Discov (2012) 1.04
A comprehensive manually curated reaction map of RANKL/RANK-signaling pathway. Database (Oxford) (2011) 0.99
NF-κB–inducing kinase plays an essential T cell–intrinsic role in graft-versus-host disease and lethal autoimmunity in mice. J Clin Invest (2011) 0.97
NIK prevents the development of hypereosinophilic syndrome-like disease in mice independent of IKKα activation. J Immunol (2012) 0.96
NF-κB-Mediated Regulation of Osteoclastogenesis. Endocrinol Metab (Seoul) (2015) 0.92
NIK stabilization in osteoclasts results in osteoporosis and enhanced inflammatory osteolysis. PLoS One (2010) 0.92
NF-κB-inducing kinase is a key regulator of inflammation-induced and tumour-associated angiogenesis. J Pathol (2014) 0.91
Structure of the nuclear factor κB-inducing kinase (NIK) kinase domain reveals a constitutively active conformation. J Biol Chem (2012) 0.90
A cell-intrinsic requirement for NF-κB-inducing kinase in CD4 and CD8 T cell memory. J Immunol (2013) 0.89
Roles for TNF-receptor associated factor 3 (TRAF3) in lymphocyte functions. Cytokine Growth Factor Rev (2013) 0.88
Osteoclasts-Key Players in Skeletal Health and Disease. Microbiol Spectr (2016) 0.88
Anti-arthritic effects of magnolol in human interleukin 1β-stimulated fibroblast-like synoviocytes and in a rat arthritis model. PLoS One (2012) 0.85
Non-canonical NF-κB signaling in rheumatoid arthritis: Dr Jekyll and Mr Hyde? Arthritis Res Ther (2015) 0.84
Translational studies in older men using testosterone to treat sarcopenia. Trans Am Clin Climatol Assoc (2014) 0.83
Methyl salicylate lactoside inhibits inflammatory response of fibroblast-like synoviocytes and joint destruction in collagen-induced arthritis in mice. Br J Pharmacol (2014) 0.82
Cell-intrinsic role for NF-kappa B-inducing kinase in peripheral maintenance but not thymic development of Foxp3+ regulatory T cells in mice. PLoS One (2013) 0.82
Tyrosine kinases in rheumatoid arthritis. J Inflamm (Lond) (2011) 0.80
Alternative NF-κB Regulates RANKL-Induced Osteoclast Differentiation and Mitochondrial Biogenesis via Independent Mechanisms. J Bone Miner Res (2015) 0.80
Carboxyl terminus of HSC70-interacting protein (CHIP) down-regulates NF-κB-inducing kinase (NIK) and suppresses NIK-induced liver injury. J Biol Chem (2015) 0.79
Intra-articular nuclear factor-κB blockade ameliorates collagen-induced arthritis in mice by eliciting regulatory T cells and macrophages. Clin Exp Immunol (2013) 0.78
Cytoplasmic hnRNPK interacts with GSK3β and is essential for the osteoclast differentiation. Sci Rep (2015) 0.78
Potent anti-inflammatory and antiproliferative effects of gambogic acid in a rat model of antigen-induced arthritis. Mediators Inflamm (2014) 0.78
NF-κB-inducing kinase increases renal tubule epithelial inflammation associated with diabetes. Exp Diabetes Res (2011) 0.78
Protective protein/cathepsin A down-regulates osteoclastogenesis by associating with and degrading NF-kappaB p50/p65. J Bone Miner Metab (2008) 0.78
Nuclear factor-kappaB inducing kinase is required for graft-versus-host disease. Haematologica (2010) 0.77
Dendritic cells require NIK for CD40-dependent cross-priming of CD8+ T cells. Proc Natl Acad Sci U S A (2015) 0.77
Effects of testosterone on lean mass gain in elderly men: systematic review with meta-analysis of controlled and randomized studies. Age (Dordr) (2015) 0.76
NLRP12 provides a critical checkpoint for osteoclast differentiation. Proc Natl Acad Sci U S A (2015) 0.76
Inflammatory osteolysis: a conspiracy against bone. J Clin Invest (2017) 0.76
The non-canonical NF-κB pathway in immunity and inflammation. Nat Rev Immunol (2017) 0.75
MicroRNA-322 inhibits inflammatory cytokine expression and promotes cell proliferation in LPS-stimulated murine macrophages by targeting NF-κB1. Biosci Rep (2016) 0.75
Glucocorticoids increase skeletal muscle NF-κB inducing kinase (NIK): links to muscle atrophy. Physiol Rep (2016) 0.75
Signaling to NF-kappaB. Genes Dev (2004) 19.78
NF-kappaB regulation in the immune system. Nat Rev Immunol (2002) 15.80
Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature (1999) 8.23
Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science (2001) 7.66
Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science (1994) 7.10
Organ-specific disease provoked by systemic autoimmunity. Cell (1996) 6.44
Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. Nat Med (1997) 5.72
Requirement for NF-kappaB in osteoclast and B-cell development. Genes Dev (1997) 5.65
From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity (1999) 5.38
BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nat Immunol (2002) 5.09
Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science (1999) 4.97
The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity (1998) 4.56
Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis. J Immunol (2001) 4.39
Lymphotoxin-alpha-deficient mice. Effects on secondary lymphoid organ development and humoral immune responsiveness. J Immunol (1995) 3.69
TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. Am J Pathol (2001) 3.53
Antigen-induced arthritis in mice. I. Induction of arthritis in various strains of mice. Arthritis Rheum (1977) 3.23
Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J Clin Invest (2003) 3.14
Defective lymphotoxin-beta receptor-induced NF-kappaB transcriptional activity in NIK-deficient mice. Science (2001) 3.11
Selective inhibition of NF-kappa B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo. Nat Med (2004) 2.94
Osteoclasts are essential for TNF-alpha-mediated joint destruction. J Clin Invest (2002) 2.85
A new mutation, aly, that induces a generalized lack of lymph nodes accompanied by immunodeficiency in mice. Eur J Immunol (1994) 2.62
Affinity maturation without germinal centres in lymphotoxin-alpha-deficient mice. Nature (1996) 2.43
In vivo imaging of NF-kappa B activity. J Immunol (2002) 2.36
The IkappaB function of NF-kappaB2 p100 controls stimulated osteoclastogenesis. J Exp Med (2003) 2.20
Genetic influences on the end-stage effector phase of arthritis. J Exp Med (2001) 1.99
Expression of osteoclast differentiation factor in rheumatoid arthritis. Arthritis Rheum (2000) 1.92
NF-kappa B in rheumatoid arthritis: a pivotal regulator of inflammation, hyperplasia, and tissue destruction. Arthritis Res (2001) 1.76
The IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks osteoclastogenesis and bone erosion in inflammatory arthritis. J Biol Chem (2004) 1.72
Abnormal immune function of hemopoietic cells from alymphoplasia (aly) mice, a natural strain with mutant NF-kappa B-inducing kinase. J Immunol (2000) 1.70
Distinct roles for the NF-kappaB1 (p50) and c-Rel transcription factors in inflammatory arthritis. J Clin Invest (2000) 1.62
On the key role of secondary lymphoid organs in antiviral immune responses studied in alymphoplastic (aly/aly) and spleenless (Hox11(-)/-) mutant mice. J Exp Med (1997) 1.59
Osteoclast differentiation is impaired in the absence of inhibitor of kappa B kinase alpha. J Biol Chem (2004) 1.30
NF-kappaB-inducing kinase is dispensable for activation of NF-kappaB in inflammatory settings but essential for lymphotoxin beta receptor activation of NF-kappaB in primary human fibroblasts. J Immunol (2001) 1.24
Direct inhibition of NF-kappa B blocks bone erosion associated with inflammatory arthritis. J Immunol (2003) 1.21
Despite ubiquitous autoantigen expression, arthritogenic autoantibody response initiates in the local lymph node. Proc Natl Acad Sci U S A (2002) 1.21
Essential role of NF-kappa B-inducing kinase in T cell activation through the TCR/CD3 pathway. J Immunol (2002) 1.10
Pathogenesis of bone erosions in rheumatoid arthritis. Curr Opin Rheumatol (2002) 1.07
Adoptive transfer of susceptibility to antigen-induced arthritis into severe combined immunodeficient (SCID) mice: role of CD4+ and CD8+ T cells. Immunol Invest (1996) 1.03
Rheumatoid arthritis--a molecular understanding. Ann Intern Med (2002) 1.02
Anti-CD4 monoclonal antibody treatment in acute and early chronic antigen-induced arthritis: influence on T helper cell activation. Clin Exp Immunol (2004) 1.01
Psoriatic arthritis: prevalence, diagnosis, and review of therapy for the dermatologist. Dermatol Clin (2004) 0.92
Impaired protective immunity and T helper 2 responses in alymphoplasia (aly) mutant mice infected with Trichinella spiralis. Immunology (2001) 0.83
Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature (2009) 9.75
The immunological synapse balances T cell receptor signaling and degradation. Science (2003) 4.94
Preferential generation of follicular B helper T cells from Foxp3+ T cells in gut Peyer's patches. Science (2009) 4.80
IL-1 mediates TNF-induced osteoclastogenesis. J Clin Invest (2005) 3.56
CD169-positive macrophages dominate antitumor immunity by crosspresenting dead cell-associated antigens. Immunity (2010) 2.37
Syk, c-Src, the alphavbeta3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption. J Cell Biol (2007) 2.27
The IkappaB function of NF-kappaB2 p100 controls stimulated osteoclastogenesis. J Exp Med (2003) 2.20
Adaptive immune regulation in the gut: T cell-dependent and T cell-independent IgA synthesis. Annu Rev Immunol (2010) 2.07
Monitoring cellular movement in vivo with photoconvertible fluorescence protein "Kaede" transgenic mice. Proc Natl Acad Sci U S A (2008) 2.04
Glucocorticoids suppress bone formation via the osteoclast. J Clin Invest (2006) 1.92
Activated regulatory T cells are the major T cell type emigrating from the skin during a cutaneous immune response in mice. J Clin Invest (2010) 1.83
Construction of an open-access database that integrates cross-reference information from the transcriptome and proteome of immune cells. Bioinformatics (2007) 1.73
RelB is the NF-kappaB subunit downstream of NIK responsible for osteoclast differentiation. Proc Natl Acad Sci U S A (2008) 1.68
U0126 and PD98059, specific inhibitors of MEK, accelerate differentiation of RAW264.7 cells into osteoclast-like cells. J Biol Chem (2002) 1.60
Runx2 determines bone maturity and turnover rate in postnatal bone development and is involved in bone loss in estrogen deficiency. Dev Dyn (2007) 1.56
Interferon-producing cells fail to induce proliferation of naive T cells but can promote expansion and T helper 1 differentiation of antigen-experienced unpolarized T cells. J Exp Med (2003) 1.54
RelA/p65 promotes osteoclast differentiation by blocking a RANKL-induced apoptotic JNK pathway in mice. J Clin Invest (2008) 1.52
Marrow stromal cells and osteoclast precursors differentially contribute to TNF-alpha-induced osteoclastogenesis in vivo. J Immunol (2004) 1.50
Preferential localization of IgG memory B cells adjacent to contracted germinal centers. Proc Natl Acad Sci U S A (2010) 1.48
Thymocyte apoptosis induced by T cell activation is mediated by glucocorticoids in vivo. J Immunol (2002) 1.39
Recirculating memory T cells are a unique subset of CD4+ T cells with a distinct phenotype and migratory pattern. J Immunol (2012) 1.35
In APCs, the autologous peptides selected by the diabetogenic I-Ag7 molecule are unique and determined by the amino acid changes in the P9 pocket. J Immunol (2002) 1.32
FHL2 inhibits the activated osteoclast in a TRAF6-dependent manner. J Clin Invest (2005) 1.25
Critical role of beta3 integrin in experimental postmenopausal osteoporosis. J Bone Miner Res (2005) 1.17
Age-related changes in bone morphology are accelerated in group VIA phospholipase A2 (iPLA2beta)-null mice. Am J Pathol (2008) 1.16
Vav1 acidic region tyrosine 174 is required for the formation of T cell receptor-induced microclusters and is essential in T cell development and activation. J Biol Chem (2006) 1.10
Noninvasive imaging of osteoclasts in parathyroid hormone-induced osteolysis using a 64Cu-labeled RGD peptide. J Nucl Med (2007) 1.10
SHIP1 negatively regulates proliferation of osteoclast precursors via Akt-dependent alterations in D-type cyclins and p27. J Immunol (2006) 1.09
Crystal Structure of the interleukin-15.interleukin-15 receptor alpha complex: insights into trans and cis presentation. J Biol Chem (2007) 1.07
Vav links the T cell antigen receptor to the actin cytoskeleton and T cell activation independently of intrinsic Guanine nucleotide exchange activity. PLoS One (2009) 1.07
Antagonism of inhibitor of apoptosis proteins increases bone metastasis via unexpected osteoclast activation. Cancer Discov (2012) 1.04
Revision of T cell receptor {alpha} chain genes is required for normal T lymphocyte development. Proc Natl Acad Sci U S A (2005) 1.04
Regulation of autoimmune diabetes by non-islet-specific T cells - a role for the glucocorticoid-induced TNF receptor. Eur J Immunol (2004) 1.04
Paradoxical dampening of anti-islet self-reactivity but promotion of diabetes by OX40 ligand. J Immunol (2003) 1.02
Male germline and embryonic stem cell lines from NOD mice: efficient derivation of GS cells from a nonpermissive strain for ES cell derivation. Biol Reprod (2009) 1.02
Defective osteoclastogenesis by IKKbeta-null precursors is a result of receptor activator of NF-kappaB ligand (RANKL)-induced JNK-dependent apoptosis and impaired differentiation. J Biol Chem (2008) 1.02
The mechanism underlying T cell help for induction of an antigen-specific in vivo humoral immune response to intact Streptococcus pneumoniae is dependent on the type of antigen. J Immunol (2002) 0.99
Combination of tumor necrosis factor α and interleukin-6 induces mouse osteoclast-like cells with bone resorption activity both in vitro and in vivo. Arthritis Rheumatol (2014) 0.95
Systemic circulation and bone recruitment of osteoclast precursors tracked by using fluorescent imaging techniques. J Immunol (2012) 0.95
Naive CD4+ T lymphocytes circulate through lymphoid organs to interact with endogenous antigens and upregulate their function. J Immunol (2010) 0.94
Specificity of peptide selection by antigen-presenting cells homozygous or heterozygous for expression of class II MHC molecules: The lack of competition. Proc Natl Acad Sci U S A (2003) 0.94
Production of healthy cloned mice from bodies frozen at -20 degrees C for 16 years. Proc Natl Acad Sci U S A (2008) 0.93
Contrasting quiescent G0 phase with mitotic cell cycling in the mouse immune system. PLoS One (2013) 0.93
IFN-γ directly inhibits TNF-α-induced osteoclastogenesis in vitro and in vivo and induces apoptosis mediated by Fas/Fas ligand interactions. Immunol Lett (2011) 0.93
Overexpression of Bcl2 in osteoblasts inhibits osteoblast differentiation and induces osteocyte apoptosis. PLoS One (2011) 0.92
Superantigen-induced TCR alpha locus secondary rearrangement: role in tolerance induction. J Immunol (2002) 0.92
Cyclin-dependent kinase inhibitor p21, via its C-terminal domain, is essential for resolution of murine inflammatory arthritis. Arthritis Rheum (2012) 0.92
NIK stabilization in osteoclasts results in osteoporosis and enhanced inflammatory osteolysis. PLoS One (2010) 0.92
Thrombospondin-1 regulates bone homeostasis through effects on bone matrix integrity and nitric oxide signaling in osteoclasts. J Bone Miner Res (2015) 0.91
Influence of bisphosphonates on orthodontic tooth movement in mice. Eur J Orthod (2009) 0.90
No requirement of trans presentations of IL-15 for human CD8 T cell proliferation. J Immunol (2010) 0.89
T cell receptor CDR3 loop length repertoire is determined primarily by features of the V(D)J recombination reaction. Eur J Immunol (2003) 0.89
Three-dimensional cephalometry using helical computer tomography: measurement error caused by head inclination. Angle Orthod (2002) 0.89
Critical role of IFN-gamma in CFA-mediated protection of NOD mice from diabetes development. Int Immunol (2009) 0.88
IL-12 inhibits TNF-alpha induced osteoclastogenesis via a T cell-independent mechanism in vivo. Bone (2009) 0.88
Osteoclasts-Key Players in Skeletal Health and Disease. Microbiol Spectr (2016) 0.88
Impediment of NEMO oligomerization inhibits osteoclastogenesis and osteolysis. J Cell Biochem (2009) 0.87
Age-dependent TCR revision mediated by interaction between alphabeta TCR and self-antigens. J Immunol (2007) 0.86
Thymic nurse cells provide microenvironment for secondary T cell receptor α rearrangement in cortical thymocytes. Proc Natl Acad Sci U S A (2012) 0.85
Experimental model of tooth movement by orthodontic force in mice and its application to tumor necrosis factor receptor-deficient mice. J Bone Miner Metab (2006) 0.85
Vitamin A-dependent transcriptional activation of the nuclear factor of activated T cells c1 (NFATc1) is critical for the development and survival of B1 cells. Proc Natl Acad Sci U S A (2010) 0.85
An antibacterial surface on dental implants, based on the photocatalytic bactericidal effect. Clin Implant Dent Relat Res (2005) 0.84
Calcium/calmodulin-signaling supports TRPV4 activation in osteoclasts and regulates bone mass. J Bone Miner Res (2012) 0.84
IL-18 inhibits TNF-alpha-induced osteoclastogenesis possibly via a T cell-independent mechanism in synergy with IL-12 in vivo. Calcif Tissue Int (2010) 0.83
Glucocorticoids and the osteoclast. Ann N Y Acad Sci (2007) 0.81
Impact of early expression of TCR alpha chain on thymocyte development. Eur J Immunol (2004) 0.81
LAT and NTAL mediate immunoglobulin E-induced sustained extracellular signal-regulated kinase activation critical for mast cell survival. Mol Cell Biol (2007) 0.81
Epidermal gammadelta T cells sense precancerous cellular dysregulation and initiate immune responses. Int Immunol (2010) 0.81
Inhibitory effects of IL-12 on experimental tooth movement and root resorption in mice. Arch Oral Biol (2011) 0.80
Anti-c-Fms antibody inhibits lipopolysaccharide-induced osteoclastogenesis in vivo. FEMS Immunol Med Microbiol (2011) 0.80
The hemoglobin receptor protein of porphyromonas gingivalis inhibits receptor activator NF-kappaB ligand-induced osteoclastogenesis from bone marrow macrophages. Infect Immun (2006) 0.79
Autoantibodies and CD4 T cells target a beta cell retroviral envelope protein in non-obese diabetic mice. Int Immunol (2003) 0.79
Relationship between sleep bruxism and sleep respiratory events in patients with obstructive sleep apnea syndrome. Sleep Breath (2014) 0.79
Selective impairment of FcepsilonRI-mediated allergic reaction in Gads-deficient mice. Int Immunol (2008) 0.78
Anti-cancer IAP antagonists promote bone metastasis: a cautionary tale. J Bone Miner Metab (2013) 0.78
Time-lapse observation of cellular function with fluorescent probe reveals novel CTL-target cell interactions. Int Immunol (2009) 0.78
Protection from lethal infection by adoptive transfer of CD8 T cells genetically engineered to express virus-specific innate immune receptor. J Immunol (2007) 0.77
Compressive force-produced CCN2 induces osteocyte apoptosis through ERK1/2 pathway. J Bone Miner Res (2014) 0.77
Inhibitory effect of interferon-γ on experimental tooth movement in mice. J Interferon Cytokine Res (2012) 0.76
Protection of IFN-gamma signaling-deficient NOD mice from diabetes by cyclophosphamide. Int Immunol (2008) 0.76
Dexamethsone suppresses bone formation via the osteoclast. Adv Exp Med Biol (2007) 0.75
Comparative proteomic analysis of a cytosolic fraction from β3 integrin-deficient cells. Cancer Genomics Proteomics (2012) 0.75
Requirement of high-affinity IL-2-IL-2R interaction for T cell anergy induction. Int Immunol (2006) 0.75
Optimizing fluorescence excitation and detection for intravital two-photon microscopy. Methods Cell Biol (2013) 0.75
Expression of pituitary adenylate cyclase-activating peptide (PACAP) and PAC1 in the periodontal ligament after tooth luxation. Cell Mol Neurobiol (2013) 0.75
Nuclear transferred embryonic stem cells for analysis of B1 B-lymphocyte development. Int Immunol (2012) 0.75